On Behalf of Cancer Patients | GenomeWeb

On Behalf of Cancer Patients

Premium

For cancer patient Adriana Jenkins, the term "personalized medicine" isn't just a slogan — it's the kind of treatment that helped extend her life when she was diagnosed with breast cancer in 2001. Jenkins participated in a clinical trial of Herceptin, which was then the latest drug made to combat a specific mutation driving a specific type of cancer, she writes in Forbes. "Herceptin likely extended my life by at least nine years," Jenkins says.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.